ArticleTranslational lung cancer research2023

Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29).

Emmanuelle Renaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.